Trials / Completed
CompletedNCT03687515
Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.
Efficacy and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization Compared With Budesonide Aqueous Nasal Spray and Oral Steroids for the Treatment of Chronic Rhinosinusitis With Polyposis.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Beijing Tongren Hospital · Academic / Other
- Sex
- All
- Age
- 23 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Topical and systemic steroids constitute the first choice in medical treatment for nasal polyps. This study aimed to evaluate the efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in the preoperative management of chronic rhinosinusitis with nasal polyposis. The second aim was to compare budesonide inhalation suspension with budesonide aqueous nasal spray and oral prednisone in nasal polyp treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | budesonide | 1mg/2ml Pulmicort Respules BIS twice daily |
| DRUG | budesonide | nasal spray 256μg BID |
| DRUG | Prednisone | oral prednisone 24mg QD |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-12-03
- Completion
- 2017-11-30
- First posted
- 2018-09-27
- Last updated
- 2018-09-27
Source: ClinicalTrials.gov record NCT03687515. Inclusion in this directory is not an endorsement.